Log In
Print this Print this

Elitek, Fasturtec, rasburicase

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionRecombinant urate-oxidase
Molecular Target Not available
Mechanism of ActionNA
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationHyperuricemia / gout
Indication DetailsTreat and prevent hyperuricemia in patients with hematological malignancies and at risk of tumor lysis syndrome; Treat hyperuricemia/gout; Treat malignancy-associated or chemotherapy-induced hyperuricemia
Regulatory Designation U.S. - Orphan Drug (Treat malignancy-associated or chemotherapy-induced hyperuricemia)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today